Immuneering (IMRX) Market Capitalization (2021 - 2026)
Immuneering's Market Capitalization was $264.88 million in Q3 2026, down 4.6% from $277.69 million a year earlier and down 18.0% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Market Capitalization (2021 - 2026) Analysis & Trends
For FY2025, Market Capitalization at Immuneering came in at $289.6 million, up 323.9% from FY2024.
- Market Capitalization shows a four-year compound annual growth rate of 7.1% (FY2021 to FY2025).
- In earlier years, Market Capitalization was $68.31 million in FY2024 (-68.2%), $215.15 million in FY2023 (+67.9%), $128.13 million in FY2022 (-41.8%) and $220.12 million in FY2021.
- The Q3 2026 figure marks the lowest quarterly Market Capitalization since Q2 2025.
- Compared with a year earlier, Market Capitalization was higher in five of the last eight quarters, with growth averaging 172.9%.
- The best year-over-year quarter for Market Capitalization over five years was Q1 2026 (growth of 523.3%); the worst was Q2 2024 (a decline of 87.2%).
- Per Business Quant data, IMRX's Market Capitalization in the three quarters before Q3 2026 was $322.84 million (Q2 2026), $340.91 million (Q1 2026) and $289.6 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Immuneering | 246.36 Mn | -378.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 264.88 Mn |
| Jun 30, 2026 | 322.84 Mn |
| Mar 31, 2026 | 340.91 Mn |
| Dec 31, 2025 | 289.60 Mn |
| Sep 30, 2025 | 277.69 Mn |
| Jun 30, 2025 | 121.28 Mn |
| Mar 31, 2025 | 54.70 Mn |
| Dec 31, 2024 | 68.31 Mn |
| Sep 30, 2024 | 77.32 Mn |
| Jun 30, 2024 | 37.96 Mn |
| Mar 31, 2024 | 85.70 Mn |
| Dec 31, 2023 | 215.15 Mn |
| Sep 30, 2023 | 224.79 Mn |
| Jun 30, 2023 | 296.73 Mn |
| Mar 31, 2023 | 257.27 Mn |
| Dec 31, 2022 | 128.13 Mn |
| Sep 30, 2022 | 378.12 Mn |
| Jun 30, 2022 | 142.78 Mn |
| Mar 31, 2022 | 170.70 Mn |
| Dec 31, 2021 | 220.12 Mn |
API Access
Immuneering Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();